A motorcyclist in his 60s has died in a crash on a main road in east Kent, police have said. The crash happened on the A299 ...

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment ...

Yuki Tsunoda was the highest-finishing driver to complete the 2024 Hungarian Grand Prix with a one-stop strategy. Tsunoda ...

The affected products were sold by retailers including Argos, B&M, DID, Lidl, Poundland, Robert Dyas, Tesco, and the Tower ...

The U.S. Food and Drug Administration has granted approval to Empaveli as the primary treatment for C3 glomerulopathy .The drug has received approval for patients over 12 years and above who work to ...

The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

C3.ai's CEO and founder, Tom Siebel, has announced his decision to step down once a new CEO is in place. C3.ai could go two different ways with its CEO search. 10 stocks we like better than C3.ai › C3 ...

We've waited quite some time for a reasonable choice of affordable small electric cars, and while they’re not exactly coming ...

Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

The full-season announcement, made in collaboration with the FIA and Formula 1, includes softer selections at Zandvoort and ...

M&A is back is in style again under President Donald Trump. That’s good news for investors in stocks such as C3.ai, Viking ...